The latest closing stock price for Blueprint Medicines as of January 21, 2025 is 111.96.
An investor who bought $1,000 worth of Blueprint Medicines stock at the IPO in 2015 would have $4,933 today, roughly 5 times their original investment - a 19.49% compound annual growth rate over 10 years.
The all-time high Blueprint Medicines stock closing price was 124.48 on December 23, 2020.
The Blueprint Medicines 52-week high stock price is 121.90, which is 8.9% above the current share price.
The Blueprint Medicines 52-week low stock price is 72.24, which is 35.5% below the current share price.
The average Blueprint Medicines stock price for the last 52 weeks is 95.10.
An investor who bought $1,000 worth of Blueprint Medicines stock at the IPO in 2015 would have $4,933 today, roughly 5 times their original investment - a 19.49% compound annual growth rate over 10 years.
The all-time high Blueprint Medicines stock closing price was 124.48 on December 23, 2020.
The Blueprint Medicines 52-week high stock price is 121.90, which is 8.9% above the current share price.
The Blueprint Medicines 52-week low stock price is 72.24, which is 35.5% below the current share price.
The average Blueprint Medicines stock price for the last 52 weeks is 95.10.